These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 16809763)
1. The scaffold protein Cybr is required for cytokine-modulated trafficking of leukocytes in vivo. Coppola V; Barrick CA; Bobisse S; Rodriguez-Galan MC; Pivetta M; Reynolds D; Howard OM; Palko ME; Esteban PF; Young HA; Rosato A; Tessarollo L Mol Cell Biol; 2006 Jul; 26(14):5249-58. PubMed ID: 16809763 [TBL] [Abstract][Full Text] [Related]
2. Cytohesin binder and regulator (cybr) is not essential for T- and dendritic-cell activation and differentiation. Watford WT; Li D; Agnello D; Durant L; Yamaoka K; Yao ZJ; Ahn HJ; Cheng TP; Hofmann SR; Cogliati T; Chen A; Hissong BD; Husa MR; Schwartzberg P; O'Shea JJ; Gadina M Mol Cell Biol; 2006 Sep; 26(17):6623-32. PubMed ID: 16914744 [TBL] [Abstract][Full Text] [Related]
3. Cybr, a cytokine-inducible protein that binds cytohesin-1 and regulates its activity. Tang P; Cheng TP; Agnello D; Wu CY; Hissong BD; Watford WT; Ahn HJ; Galon J; Moss J; Vaughan M; O'Shea JJ; Gadina M Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2625-9. PubMed ID: 11867758 [TBL] [Abstract][Full Text] [Related]
4. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone. Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766 [TBL] [Abstract][Full Text] [Related]
5. Distribution of cycling T lymphocytes in blood and lymphoid organs during immune responses. Vasseur F; Le Campion A; Pavlovitch JH; Pénit C J Immunol; 1999 May; 162(9):5164-72. PubMed ID: 10227988 [TBL] [Abstract][Full Text] [Related]
7. Visualization of a primary anti-tumor immune response by positron emission tomography. Shu CJ; Guo S; Kim YJ; Shelly SM; Nijagal A; Ray P; Gambhir SS; Radu CG; Witte ON Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17412-7. PubMed ID: 16293690 [TBL] [Abstract][Full Text] [Related]
8. Anti-L-selectin monoclonal antibody treatment in mice enhances tumor growth by preventing CTL sensitization in peripheral lymph nodes draining the tumor area. Rosato A; Zambon A; Macino B; Mandruzzato S; Bronte V; Milan G; Zanovello P; Collavo D Int J Cancer; 1996 Mar; 65(6):847-51. PubMed ID: 8631602 [TBL] [Abstract][Full Text] [Related]
9. Role of Cybr, a cytohesin binder and regulator, in CD4(+) T-cell function and host immunity. Chang SL; Chang CL; Huang PI; Tao MH; Yang WC Mol Immunol; 2009 Oct; 46(16):3218-23. PubMed ID: 19744714 [TBL] [Abstract][Full Text] [Related]
10. Effects of amphetamine on the development of Moloney sarcoma virus-induced tumors in mice. Freire-Garabal M; Nuñez-Iglesias MJ; Rey-Méndez M; Pereiro-Raposo MD; Riveiro P; Fernández-Rial JC; Losada C; Gandoy M; Mayán JM Oncol Rep; 1998; 5(2):381-3. PubMed ID: 9468562 [TBL] [Abstract][Full Text] [Related]
11. WASP deficiency leads to global defects of directed leukocyte migration in vitro and in vivo. Snapper SB; Meelu P; Nguyen D; Stockton BM; Bozza P; Alt FW; Rosen FS; von Andrian UH; Klein C J Leukoc Biol; 2005 Jun; 77(6):993-8. PubMed ID: 15774550 [TBL] [Abstract][Full Text] [Related]
12. Role of adhesion molecules in the immune reaction to M-MSV-induced tumors. Rosato A; Bronte V; Mandruzzato S; Zambon A; Calderazzo F; Biasi G; Zanovello P; Collavo D Int J Cancer Suppl; 1992; 7():24-7. PubMed ID: 1385341 [TBL] [Abstract][Full Text] [Related]
13. Trafficking of CD44-deficient murine lymphocytes under normal and inflammatory conditions. Stoop R; Gál I; Glant TT; McNeish JD; Mikecz K Eur J Immunol; 2002 Sep; 32(9):2532-42. PubMed ID: 12207337 [TBL] [Abstract][Full Text] [Related]
14. Adoptive transfer of bone marrow CD8 T lymphocytes confers full protection vs. tumor growth in M-MSV/MuLV experimental model. Facchinetti A; Biasi G Immunol Lett; 2012 May; 144(1-2):78-9. PubMed ID: 22465204 [No Abstract] [Full Text] [Related]
16. Optimal T Cell Activation and B Cell Antibody Responses In Vivo Require the Interaction between Leukocyte Function-Associated Antigen-1 and Kindlin-3. Morrison VL; Uotila LM; Llort Asens M; Savinko T; Fagerholm SC J Immunol; 2015 Jul; 195(1):105-15. PubMed ID: 25987740 [TBL] [Abstract][Full Text] [Related]
17. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors. Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385 [No Abstract] [Full Text] [Related]
18. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens. Ng AK; Ames RS; McIntire RK; Herberman RB Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218 [TBL] [Abstract][Full Text] [Related]
19. Induction of Moloney murine sarcoma virus tolerance in adult mice by anti-CD4 monoclonal antibody treatment. Biasi G; Mazzocchi M; Facchinetti A; Panozzo M; Zanovello P; Collavo D; Chieco-Bianchi L Cancer Res; 1990 Sep; 50(17 Suppl):5703S-5706S. PubMed ID: 2167167 [TBL] [Abstract][Full Text] [Related]
20. The in vivo role of leukocyte function-associated antigen-1 in cytotoxic cell activity against tumors induced by Moloney-murine sarcoma/leukemia retroviral complex. Rosato A; Bronte V; Pollis F; Mandruzzato S; Zambon A; Zanovello P; Collavo D Leukemia; 1992; 6 Suppl 3():166S-167S. PubMed ID: 1602816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]